CCRN — Cross Country Healthcare, Inc.

Summary of Cross Country Healthcare (CCRN) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $237 million, down 5% sequentially and 24% year-over-year.
• Full Year Revenue: $1.05 billion, down 22% from the previous year.
• Gross Profit: $48 million, resulting in a gross margin of 20.3%, down slightly from the previous quarter but up from the prior year.
• SG&A Expenses: $51 million for Q4, up 9% sequentially but down 8% year-over-year.
• Adjusted EBITDA: $4 million for Q4, with a margin of 1.7%; full year adjusted EBITDA was $27 million (2.5% margin).
• Cash Position: $109 million in cash, no debt, and $18 million in cash generated from operations for Q4.

2. Strategic Updates and Business Highlights

• The company is focusing on restoring momentum post-merger, emphasizing operational rigor and technology-driven workforce solutions.
• Key initiatives include expanding market share within large health systems, improving operational efficiency, and leveraging technology like Intellify, a workforce intelligence platform.
• The company aims to enhance its technology offerings across multiple sectors, including home-based and education staffing.
• Investments in revenue producers (recruiters and sales professionals) are expected to drive organic growth.

3. Forward Guidance and Outlook

• Q1 2026 Guidance: Revenue expected between $235 million and $240 million, with adjusted EBITDA between $4 million and $5 million (approximately 2% margin).
• The company anticipates exiting 2026 with a revenue run rate exceeding $1 billion and adjusted EBITDA margins of 4% to 5%.
• Sequential growth is expected throughout 2026, driven by improved market conditions and operational efficiencies.

4. Bad News, Challenges, or Points of Concern

• The company experienced significant revenue declines due to a normalization in contingent labor utilization, particularly in the Travel, Nurse, and Allied segments.
• Competitive pressures in the staffing market are expected to continue, particularly affecting gross margins in the travel business.
• Noncash impairment charges of $78 million were recorded due to the decline in share price following the termination of the merger agreement.
• The company is navigating a challenging labor market with ongoing strike activities, although they have not significantly impacted revenue yet.

5. Notable Q&A Insights

• Management expressed confidence in achieving revenue and margin targets, citing a strong pipeline and investments in technology and personnel.
• There is optimism about the stabilization of the travel staffing market, with expectations of sequential growth in the number of travelers on assignment.
• The company is exploring strategic acquisitions but is focused on enhancing its technology platform rather than expanding its supply partner base.
• Concerns were raised about the impact of federal funding changes on the healthcare system, but management noted no immediate adverse effects on their operations.

Overall, while Cross Country Healthcare faces challenges in the current market environment, the leadership is optimistic about future growth driven by strategic investments and operational improvements.